

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of hypersensitivity (GO:0002883) | 7.69106679 |
| 2 | thrombin receptor signaling pathway (GO:0070493) | 7.31831261 |
| 3 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 6.92367783 |
| 4 | positive regulation of mast cell degranulation (GO:0043306) | 6.92367783 |
| 5 | tyrosine phosphorylation of STAT protein (GO:0007260) | 6.88253097 |
| 6 | production of molecular mediator involved in inflammatory response (GO:0002532) | 6.73913365 |
| 7 | leukotriene biosynthetic process (GO:0019370) | 5.89764311 |
| 8 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 5.78491678 |
| 9 | positive regulation of mast cell activation (GO:0033005) | 5.65839594 |
| 10 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 5.22409434 |
| 11 | positive regulation of leukocyte degranulation (GO:0043302) | 5.11249664 |
| 12 | leukotriene metabolic process (GO:0006691) | 4.73673001 |
| 13 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.71781255 |
| 14 | regulation of guanylate cyclase activity (GO:0031282) | 4.68578065 |
| 15 | regulation of mast cell degranulation (GO:0043304) | 4.53970524 |
| 16 | intestinal absorption (GO:0050892) | 4.45202534 |
| 17 | peptide hormone processing (GO:0016486) | 4.39901813 |
| 18 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.30624543 |
| 19 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.29538374 |
| 20 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 4.18787739 |
| 21 | definitive hemopoiesis (GO:0060216) | 4.03985334 |
| 22 | L-fucose catabolic process (GO:0042355) | 3.97769852 |
| 23 | fucose catabolic process (GO:0019317) | 3.97769852 |
| 24 | L-fucose metabolic process (GO:0042354) | 3.97769852 |
| 25 | desmosome organization (GO:0002934) | 3.94602839 |
| 26 | epoxygenase P450 pathway (GO:0019373) | 3.92930845 |
| 27 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.86163026 |
| 28 | regulation of mast cell activation (GO:0033003) | 3.85089256 |
| 29 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.81582522 |
| 30 | regulation of chemokine secretion (GO:0090196) | 3.78934265 |
| 31 | flavonoid metabolic process (GO:0009812) | 3.76286892 |
| 32 | lipoxygenase pathway (GO:0019372) | 3.73209084 |
| 33 | histamine secretion (GO:0001821) | 3.72684817 |
| 34 | sulfation (GO:0051923) | 3.72331799 |
| 35 | positive regulation of regulated secretory pathway (GO:1903307) | 3.71772384 |
| 36 | indolalkylamine metabolic process (GO:0006586) | 3.68738166 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 3.68439593 |
| 38 | positive regulation of chemokine secretion (GO:0090197) | 3.67216326 |
| 39 | regulation of leukocyte degranulation (GO:0043300) | 3.61580006 |
| 40 | transepithelial transport (GO:0070633) | 3.60123145 |
| 41 | DNA deamination (GO:0045006) | 3.60088091 |
| 42 | drug catabolic process (GO:0042737) | 3.58913879 |
| 43 | intestinal cholesterol absorption (GO:0030299) | 3.58641028 |
| 44 | histamine transport (GO:0051608) | 3.55507737 |
| 45 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.55102584 |
| 46 | behavioral response to nicotine (GO:0035095) | 3.52297366 |
| 47 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.47842142 |
| 48 | phospholipid scrambling (GO:0017121) | 3.45756511 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 3.43822642 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 3.43822642 |
| 51 | tryptophan catabolic process (GO:0006569) | 3.43822642 |
| 52 | vitamin biosynthetic process (GO:0009110) | 3.43098521 |
| 53 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.42658566 |
| 54 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.38354901 |
| 55 | interferon-gamma production (GO:0032609) | 3.36636039 |
| 56 | megakaryocyte development (GO:0035855) | 3.36545007 |
| 57 | drug metabolic process (GO:0017144) | 3.36377825 |
| 58 | exogenous drug catabolic process (GO:0042738) | 3.35669510 |
| 59 | mast cell activation (GO:0045576) | 3.35611813 |
| 60 | positive regulation of fatty acid transport (GO:2000193) | 3.32827742 |
| 61 | lipoprotein transport (GO:0042953) | 3.32490284 |
| 62 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.32343140 |
| 63 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.31520332 |
| 64 | axoneme assembly (GO:0035082) | 3.30347054 |
| 65 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.25504548 |
| 66 | cytidine metabolic process (GO:0046087) | 3.22799502 |
| 67 | cytidine catabolic process (GO:0006216) | 3.22799502 |
| 68 | cytidine deamination (GO:0009972) | 3.22799502 |
| 69 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.20494648 |
| 70 | regulation of interleukin-8 secretion (GO:2000482) | 3.19682361 |
| 71 | mast cell degranulation (GO:0043303) | 3.17684339 |
| 72 | mast cell activation involved in immune response (GO:0002279) | 3.17684339 |
| 73 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.16820300 |
| 74 | kidney morphogenesis (GO:0060993) | 3.16771775 |
| 75 | dendritic cell chemotaxis (GO:0002407) | 3.12521878 |
| 76 | positive regulation of icosanoid secretion (GO:0032305) | 3.12037021 |
| 77 | germ cell migration (GO:0008354) | 3.09435978 |
| 78 | digestion (GO:0007586) | 3.08895405 |
| 79 | cilium movement (GO:0003341) | 3.08512791 |
| 80 | dendritic cell migration (GO:0036336) | 3.07392809 |
| 81 | platelet dense granule organization (GO:0060155) | 3.06500409 |
| 82 | epithelial cilium movement (GO:0003351) | 3.06141998 |
| 83 | regulation of cGMP biosynthetic process (GO:0030826) | 3.04296281 |
| 84 | vitamin A metabolic process (GO:0006776) | 3.02582227 |
| 85 | positive regulation of macrophage differentiation (GO:0045651) | 2.97237698 |
| 86 | regulation of regulated secretory pathway (GO:1903305) | 2.95064209 |
| 87 | icosanoid biosynthetic process (GO:0046456) | 2.93849649 |
| 88 | fatty acid derivative biosynthetic process (GO:1901570) | 2.93849649 |
| 89 | glycerol metabolic process (GO:0006071) | 2.93685242 |
| 90 | cellular ketone body metabolic process (GO:0046950) | 2.92706374 |
| 91 | bile acid and bile salt transport (GO:0015721) | 2.92640861 |
| 92 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.92024168 |
| 93 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.92024168 |
| 94 | endocrine process (GO:0050886) | 2.92024168 |
| 95 | sulfur compound transport (GO:0072348) | 2.91289560 |
| 96 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.89715621 |
| 97 | sulfate transmembrane transport (GO:1902358) | 2.88936777 |
| 98 | tryptophan metabolic process (GO:0006568) | 2.88914662 |
| 99 | kynurenine metabolic process (GO:0070189) | 2.86911113 |
| 100 | negative regulation of mast cell activation (GO:0033004) | 2.85994229 |
| 101 | vitamin transmembrane transport (GO:0035461) | 2.85890987 |
| 102 | indole-containing compound metabolic process (GO:0042430) | 2.83831170 |
| 103 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.83409405 |
| 104 | cobalamin metabolic process (GO:0009235) | 2.83336113 |
| 105 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.82889018 |
| 106 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.81660917 |
| 107 | primary amino compound metabolic process (GO:1901160) | 2.81492578 |
| 108 | hepatocyte apoptotic process (GO:0097284) | 2.80794562 |
| 109 | alkaloid metabolic process (GO:0009820) | 2.80264781 |
| 110 | quinone biosynthetic process (GO:1901663) | 2.79867260 |
| 111 | glucuronate metabolic process (GO:0019585) | 2.79822560 |
| 112 | uronic acid metabolic process (GO:0006063) | 2.79822560 |
| 113 | ketone body metabolic process (GO:1902224) | 2.77646408 |
| 114 | positive regulation of acute inflammatory response (GO:0002675) | 2.77248884 |
| 115 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.77048329 |
| 116 | arginine metabolic process (GO:0006525) | 2.76761706 |
| 117 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.75267011 |
| 118 | cellular glucuronidation (GO:0052695) | 2.73474837 |
| 119 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.71964334 |
| 120 | hemidesmosome assembly (GO:0031581) | 2.71271167 |
| 121 | axonemal dynein complex assembly (GO:0070286) | 2.71177287 |
| 122 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.70590644 |
| 123 | regulation of cellular extravasation (GO:0002691) | 2.70246925 |
| 124 | proline transport (GO:0015824) | 2.69617779 |
| 125 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.67636391 |
| 126 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.67636391 |
| 127 | fat-soluble vitamin metabolic process (GO:0006775) | 2.67383329 |
| 128 | auditory receptor cell differentiation (GO:0042491) | 2.67043959 |
| 129 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.66285245 |
| 130 | toxin transport (GO:1901998) | 2.63820105 |
| 131 | notochord development (GO:0030903) | 2.63525321 |
| 132 | regulation of cGMP metabolic process (GO:0030823) | 2.61954884 |
| 133 | actin filament depolymerization (GO:0030042) | 2.61418517 |
| 134 | cellular response to ATP (GO:0071318) | 2.60146181 |
| 135 | actin filament polymerization (GO:0030041) | 2.59110150 |
| 136 | photoreceptor cell maintenance (GO:0045494) | 2.58685598 |
| 137 | parturition (GO:0007567) | 2.57912839 |
| 138 | positive regulation of respiratory burst (GO:0060267) | 2.57874290 |
| 139 | vitamin transport (GO:0051180) | 2.56683353 |
| 140 | serotonin metabolic process (GO:0042428) | 2.56227455 |
| 141 | negative regulation of bone resorption (GO:0045779) | 2.56130728 |
| 142 | urate metabolic process (GO:0046415) | 2.56093378 |
| 143 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.54773650 |
| 144 | positive regulation of fatty acid oxidation (GO:0046321) | 2.54705771 |
| 145 | polyol transport (GO:0015791) | 2.54595030 |
| 146 | phenol-containing compound catabolic process (GO:0019336) | 2.54410885 |
| 147 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.53942550 |
| 148 | sulfate transport (GO:0008272) | 2.53667431 |
| 149 | excretion (GO:0007588) | 2.53171870 |
| 150 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.52695556 |
| 151 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.52695556 |
| 152 | regulation of systemic arterial blood pressure (GO:0003073) | 2.51925135 |
| 153 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.51630972 |
| 154 | peptide catabolic process (GO:0043171) | 2.51580515 |
| 155 | glutathione derivative metabolic process (GO:1901685) | 2.51550300 |
| 156 | glutathione derivative biosynthetic process (GO:1901687) | 2.51550300 |
| 157 | membrane repolarization during action potential (GO:0086011) | 2.51516336 |
| 158 | thyroid hormone metabolic process (GO:0042403) | 2.50953579 |
| 159 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.50477140 |
| 160 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.50448034 |
| 161 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.49837621 |
| 162 | cytokine metabolic process (GO:0042107) | 2.49451169 |
| 163 | digestive system process (GO:0022600) | 2.49253797 |
| 164 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.48992693 |
| 165 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.48662234 |
| 166 | adenosine metabolic process (GO:0046085) | 2.48166454 |
| 167 | benzene-containing compound metabolic process (GO:0042537) | 2.47888438 |
| 168 | negative regulation of phagocytosis (GO:0050765) | 2.47380409 |
| 169 | endocrine pancreas development (GO:0031018) | 2.47204755 |
| 170 | regulation of RIG-I signaling pathway (GO:0039535) | 2.45847430 |
| 171 | cytokine biosynthetic process (GO:0042089) | 2.45566974 |
| 172 | alditol metabolic process (GO:0019400) | 2.45267249 |
| 173 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.44397215 |
| 174 | cellular response to exogenous dsRNA (GO:0071360) | 2.44367451 |
| 175 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.43823514 |
| 176 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.43823514 |
| 177 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.43516313 |
| 178 | L-ascorbic acid metabolic process (GO:0019852) | 2.42923042 |
| 179 | production of molecular mediator of immune response (GO:0002440) | 2.42111025 |
| 180 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.42005573 |
| 181 | intestinal epithelial cell development (GO:0060576) | 2.41048201 |
| 182 | oligosaccharide catabolic process (GO:0009313) | 2.40544836 |
| 183 | sphingomyelin metabolic process (GO:0006684) | 2.39967398 |
| 184 | positive regulation of extracellular matrix organization (GO:1903055) | 2.39911552 |
| 185 | regulation of protein glycosylation (GO:0060049) | 2.39815856 |
| 186 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.38431544 |
| 187 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.38274389 |
| 188 | regulation of macrophage differentiation (GO:0045649) | 2.38196389 |
| 189 | secretory granule organization (GO:0033363) | 2.37168763 |
| 190 | cytokine production involved in immune response (GO:0002367) | 2.36838511 |
| 191 | adhesion of symbiont to host cell (GO:0044650) | 2.36297030 |
| 192 | angiotensin maturation (GO:0002003) | 11.9970655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.26543295 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.80597399 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.49430577 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.11067490 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.10777455 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97433032 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.66951773 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.63047947 |
| 9 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.61991668 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.49616513 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.47520725 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.37562701 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.34369916 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.12983152 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.10945455 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.07439863 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.03154162 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.02372067 |
| 19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.94908096 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.94455177 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87717372 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85330271 |
| 23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.81689887 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81244600 |
| 25 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.81195470 |
| 26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80078291 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78319842 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77918410 |
| 29 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.76324299 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.75922961 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75922211 |
| 32 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73770750 |
| 33 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.72476153 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71030294 |
| 35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70786518 |
| 36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.70383294 |
| 37 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.69028433 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.68554041 |
| 39 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68268757 |
| 40 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.65396066 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.65050287 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63647256 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.63313886 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.61159436 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61142634 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59522569 |
| 47 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.57919844 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.56113967 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56092432 |
| 50 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.55672442 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.53989159 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53247534 |
| 53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51295453 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49932792 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48316821 |
| 56 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.48292689 |
| 57 | FUS_26573619_Chip-Seq_HEK293_Human | 1.48055652 |
| 58 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.47047754 |
| 59 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.47047754 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46232701 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.44468175 |
| 62 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.44165236 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42664326 |
| 64 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41473199 |
| 65 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40606732 |
| 66 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.40240025 |
| 67 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.39259468 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38820641 |
| 69 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.37235355 |
| 70 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.37235355 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37027067 |
| 72 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36172444 |
| 73 | EWS_26573619_Chip-Seq_HEK293_Human | 1.35952734 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33929806 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33600046 |
| 76 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32673584 |
| 77 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.32310615 |
| 78 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.31149544 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30789839 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.30137146 |
| 81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.29318228 |
| 82 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29059599 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27513290 |
| 84 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26964428 |
| 85 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26906669 |
| 86 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26906669 |
| 87 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.26049021 |
| 88 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.26049021 |
| 89 | CJUN_26792858_Chip-Seq_BT549_Human | 1.25957935 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25611019 |
| 91 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25320180 |
| 92 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24696607 |
| 93 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.23315445 |
| 94 | NCOR_22424771_ChIP-Seq_293T_Human | 1.23192221 |
| 95 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21062384 |
| 96 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.21010545 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 1.20622225 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20568144 |
| 99 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.20544406 |
| 100 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.18773404 |
| 101 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18686780 |
| 102 | MYB_26560356_Chip-Seq_TH2_Human | 1.18172748 |
| 103 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18146697 |
| 104 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.17880477 |
| 105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17616092 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17580163 |
| 107 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.17526654 |
| 108 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17333904 |
| 109 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16466227 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15110077 |
| 111 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13673376 |
| 112 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.13348823 |
| 113 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.11772055 |
| 114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11420705 |
| 115 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.11401060 |
| 116 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11400772 |
| 117 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11372898 |
| 118 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09640036 |
| 119 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09440903 |
| 120 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.09422566 |
| 121 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.08888207 |
| 122 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08733222 |
| 123 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08701393 |
| 124 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08492512 |
| 125 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08022140 |
| 126 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07669480 |
| 127 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07126400 |
| 128 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06984349 |
| 129 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06354636 |
| 130 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.06088263 |
| 131 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05670374 |
| 132 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05117236 |
| 133 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04748505 |
| 134 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04043516 |
| 135 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.03754882 |
| 136 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.02554766 |
| 137 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02532541 |
| 138 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02317684 |
| 139 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.01988151 |
| 140 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01062540 |
| 141 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00779772 |
| 142 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00676147 |
| 143 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00276156 |
| 144 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.99753298 |
| 145 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.99106015 |
| 146 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96485392 |
| 147 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96224857 |
| 148 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95533915 |
| 149 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94910235 |
| 150 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.94140205 |
| 151 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93650719 |
| 152 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93285618 |
| 153 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.92309132 |
| 154 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91717759 |
| 155 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.91033537 |
| 156 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90382114 |
| 157 | P300_19829295_ChIP-Seq_ESCs_Human | 0.90012761 |
| 158 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89433951 |
| 159 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89433951 |
| 160 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88454634 |
| 161 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87557369 |
| 162 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.86963072 |
| 163 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86864231 |
| 164 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85085393 |
| 165 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84463938 |
| 166 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.84338554 |
| 167 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.83687055 |
| 168 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.82913765 |
| 169 | MYB_26560356_Chip-Seq_TH1_Human | 0.82180372 |
| 170 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.82147677 |
| 171 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.80711255 |
| 172 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79969674 |
| 173 | MAF_26560356_Chip-Seq_TH1_Human | 0.77616315 |
| 174 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.76577157 |
| 175 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.76409821 |
| 176 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.75582076 |
| 177 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.74809488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 3.38543642 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 3.27473062 |
| 3 | MP0000465_gastrointestinal_hemorrhage | 3.26436990 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.03488592 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 3.01074667 |
| 6 | MP0002254_reproductive_system_inflammat | 2.91048718 |
| 7 | MP0003866_abnormal_defecation | 2.69850848 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.68985547 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.64054065 |
| 10 | MP0005360_urolithiasis | 2.54411323 |
| 11 | MP0010155_abnormal_intestine_physiology | 2.54208090 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.54131526 |
| 13 | MP0001873_stomach_inflammation | 2.53676432 |
| 14 | MP0000383_abnormal_hair_follicle | 2.46722446 |
| 15 | MP0003436_decreased_susceptibility_to | 2.32187208 |
| 16 | MP0001188_hyperpigmentation | 2.31609420 |
| 17 | MP0005365_abnormal_bile_salt | 2.26093390 |
| 18 | MP0005646_abnormal_pituitary_gland | 2.24984043 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.19841077 |
| 20 | MP0004147_increased_porphyrin_level | 2.17391278 |
| 21 | MP0001663_abnormal_digestive_system | 2.14801813 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 2.11792478 |
| 23 | MP0010678_abnormal_skin_adnexa | 2.10486679 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 2.07935600 |
| 25 | MP0005174_abnormal_tail_pigmentation | 2.05685736 |
| 26 | MP0005671_abnormal_response_to | 2.01882844 |
| 27 | MP0008872_abnormal_physiological_respon | 2.00395763 |
| 28 | MP0001485_abnormal_pinna_reflex | 1.98142419 |
| 29 | MP0005332_abnormal_amino_acid | 1.93320531 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.92949309 |
| 31 | MP0000490_abnormal_crypts_of | 1.92812217 |
| 32 | MP0002933_joint_inflammation | 1.92121653 |
| 33 | MP0005310_abnormal_salivary_gland | 1.87640997 |
| 34 | MP0001666_abnormal_nutrient_absorption | 1.84676409 |
| 35 | MP0005551_abnormal_eye_electrophysiolog | 1.81848026 |
| 36 | MP0001790_abnormal_immune_system | 1.81447830 |
| 37 | MP0005387_immune_system_phenotype | 1.81447830 |
| 38 | MP0001835_abnormal_antigen_presentation | 1.81367122 |
| 39 | MP0001501_abnormal_sleep_pattern | 1.80760569 |
| 40 | MP0000372_irregular_coat_pigmentation | 1.80468478 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.78723264 |
| 42 | MP0005381_digestive/alimentary_phenotyp | 1.77585002 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.77303523 |
| 44 | MP0009785_altered_susceptibility_to | 1.75651452 |
| 45 | MP0002419_abnormal_innate_immunity | 1.73113615 |
| 46 | MP0005670_abnormal_white_adipose | 1.69777066 |
| 47 | MP0002102_abnormal_ear_morphology | 1.69166119 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.68196564 |
| 49 | MP0002163_abnormal_gland_morphology | 1.67835499 |
| 50 | MP0000462_abnormal_digestive_system | 1.67566777 |
| 51 | MP0005367_renal/urinary_system_phenotyp | 1.65805691 |
| 52 | MP0000516_abnormal_urinary_system | 1.65805691 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.63674773 |
| 54 | MP0001819_abnormal_immune_cell | 1.61301621 |
| 55 | MP0005025_abnormal_response_to | 1.60474923 |
| 56 | MP0003283_abnormal_digestive_organ | 1.59808381 |
| 57 | MP0005636_abnormal_mineral_homeostasis | 1.59358933 |
| 58 | MP0004134_abnormal_chest_morphology | 1.58141127 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.57554854 |
| 60 | MP0004947_skin_inflammation | 1.57381295 |
| 61 | MP0001800_abnormal_humoral_immune | 1.57291640 |
| 62 | MP0005000_abnormal_immune_tolerance | 1.57233254 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.56966304 |
| 64 | MP0003879_abnormal_hair_cell | 1.56446014 |
| 65 | MP0004885_abnormal_endolymph | 1.52771611 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 1.50382308 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.50117611 |
| 68 | MP0000538_abnormal_urinary_bladder | 1.49948760 |
| 69 | MP0003941_abnormal_skin_development | 1.48884103 |
| 70 | MP0003718_maternal_effect | 1.48037613 |
| 71 | MP0003646_muscle_fatigue | 1.43948066 |
| 72 | MP0000343_altered_response_to | 1.43355884 |
| 73 | MP0002723_abnormal_immune_serum | 1.42010377 |
| 74 | MP0005645_abnormal_hypothalamus_physiol | 1.41940686 |
| 75 | MP0009379_abnormal_foot_pigmentation | 1.41360197 |
| 76 | MP0001756_abnormal_urination | 1.41158585 |
| 77 | MP0006054_spinal_hemorrhage | 1.40840371 |
| 78 | MP0003638_abnormal_response/metabolism_ | 1.40177209 |
| 79 | MP0000230_abnormal_systemic_arterial | 1.38847437 |
| 80 | MP0009333_abnormal_splenocyte_physiolog | 1.37351145 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 1.35468871 |
| 82 | MP0009764_decreased_sensitivity_to | 1.34810257 |
| 83 | MP0002098_abnormal_vibrissa_morphology | 1.33658954 |
| 84 | MP0003252_abnormal_bile_duct | 1.33644049 |
| 85 | MP0001845_abnormal_inflammatory_respons | 1.32847491 |
| 86 | MP0001764_abnormal_homeostasis | 1.31080675 |
| 87 | MP0000427_abnormal_hair_cycle | 1.30567481 |
| 88 | MP0002009_preneoplasia | 1.28443310 |
| 89 | MP0002398_abnormal_bone_marrow | 1.24771488 |
| 90 | MP0002638_abnormal_pupillary_reflex | 1.23747047 |
| 91 | MP0004808_abnormal_hematopoietic_stem | 1.23314211 |
| 92 | MP0002909_abnormal_adrenal_gland | 1.22154407 |
| 93 | MP0002396_abnormal_hematopoietic_system | 1.21657065 |
| 94 | MP0001270_distended_abdomen | 1.21137795 |
| 95 | MP0006082_CNS_inflammation | 1.19752974 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 1.19642823 |
| 97 | MP0002796_impaired_skin_barrier | 1.18413414 |
| 98 | MP0010352_gastrointestinal_tract_polyps | 1.18343166 |
| 99 | MP0001216_abnormal_epidermal_layer | 1.17592799 |
| 100 | MP0002405_respiratory_system_inflammati | 1.16494367 |
| 101 | MP0005390_skeleton_phenotype | 1.14923224 |
| 102 | MP0006072_abnormal_retinal_apoptosis | 1.14788053 |
| 103 | MP0008877_abnormal_DNA_methylation | 1.13595666 |
| 104 | MP0009840_abnormal_foam_cell | 1.13332503 |
| 105 | MP0003787_abnormal_imprinting | 1.12912444 |
| 106 | MP0000015_abnormal_ear_pigmentation | 1.12847886 |
| 107 | MP0002138_abnormal_hepatobiliary_system | 1.11908360 |
| 108 | MP0003724_increased_susceptibility_to | 1.11607343 |
| 109 | MP0001346_abnormal_lacrimal_gland | 1.11070026 |
| 110 | MP0003795_abnormal_bone_structure | 1.11007970 |
| 111 | MP0002160_abnormal_reproductive_system | 1.10963993 |
| 112 | MP0005448_abnormal_energy_balance | 1.09679628 |
| 113 | MP0000477_abnormal_intestine_morphology | 1.08557097 |
| 114 | MP0001765_abnormal_ion_homeostasis | 1.07975285 |
| 115 | MP0005389_reproductive_system_phenotype | 1.07861680 |
| 116 | MP0000569_abnormal_digit_pigmentation | 1.07108612 |
| 117 | MP0001968_abnormal_touch/_nociception | 1.06103752 |
| 118 | MP0005253_abnormal_eye_physiology | 1.03595755 |
| 119 | MP0000716_abnormal_immune_system | 1.03197936 |
| 120 | MP0004381_abnormal_hair_follicle | 1.02856412 |
| 121 | MP0002998_abnormal_bone_remodeling | 1.01974727 |
| 122 | MP0002938_white_spotting | 1.01871956 |
| 123 | MP0009745_abnormal_behavioral_response | 0.99485588 |
| 124 | MP0002722_abnormal_immune_system | 0.99030486 |
| 125 | MP0005075_abnormal_melanosome_morpholog | 0.98995559 |
| 126 | MP0002272_abnormal_nervous_system | 0.97805594 |
| 127 | MP0001853_heart_inflammation | 0.96572495 |
| 128 | MP0003136_yellow_coat_color | 0.96473804 |
| 129 | MP0005409_darkened_coat_color | 0.96056444 |
| 130 | MP0001664_abnormal_digestion | 0.94893306 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.94601532 |
| 132 | MP0000631_abnormal_neuroendocrine_gland | 0.94600252 |
| 133 | MP0000163_abnormal_cartilage_morphology | 0.94347304 |
| 134 | MP0005379_endocrine/exocrine_gland_phen | 0.93405024 |
| 135 | MP0002118_abnormal_lipid_homeostasis | 0.91815728 |
| 136 | MP0000467_abnormal_esophagus_morphology | 0.91582700 |
| 137 | MP0000377_abnormal_hair_follicle | 0.91185863 |
| 138 | MP0009697_abnormal_copulation | 0.90931577 |
| 139 | MP0002095_abnormal_skin_pigmentation | 0.90871172 |
| 140 | MP0002429_abnormal_blood_cell | 0.90537515 |
| 141 | MP0002113_abnormal_skeleton_development | 0.90475474 |
| 142 | MP0005171_absent_coat_pigmentation | 0.90082185 |
| 143 | MP0008469_abnormal_protein_level | 0.88785423 |
| 144 | MP0002876_abnormal_thyroid_physiology | 0.88387947 |
| 145 | MP0001986_abnormal_taste_sensitivity | 0.88231792 |
| 146 | MP0001970_abnormal_pain_threshold | 0.88220375 |
| 147 | MP0004043_abnormal_pH_regulation | 0.87998751 |
| 148 | MP0003763_abnormal_thymus_physiology | 0.87379548 |
| 149 | MP0002282_abnormal_trachea_morphology | 0.87132726 |
| 150 | MP0002733_abnormal_thermal_nociception | 0.86916538 |
| 151 | MP0002136_abnormal_kidney_physiology | 0.86130339 |
| 152 | MP0005166_decreased_susceptibility_to | 0.86115511 |
| 153 | MP0003011_delayed_dark_adaptation | 0.86111957 |
| 154 | MP0003453_abnormal_keratinocyte_physiol | 0.86020777 |
| 155 | MP0002693_abnormal_pancreas_physiology | 0.85114431 |
| 156 | MP0005377_hearing/vestibular/ear_phenot | 0.84835880 |
| 157 | MP0003878_abnormal_ear_physiology | 0.84835880 |
| 158 | MP0001919_abnormal_reproductive_system | 0.81857388 |
| 159 | MP0009780_abnormal_chondrocyte_physiolo | 0.81204178 |
| 160 | MP0005408_hypopigmentation | 0.80906991 |
| 161 | MP0002736_abnormal_nociception_after | 0.77917045 |
| 162 | MP0008775_abnormal_heart_ventricle | 0.77046678 |
| 163 | MP0002734_abnormal_mechanical_nocicepti | 0.76932358 |
| 164 | MP0009046_muscle_twitch | 0.76071326 |
| 165 | MP0004142_abnormal_muscle_tone | 0.75582641 |
| 166 | MP0003953_abnormal_hormone_level | 0.75407216 |
| 167 | MP0002557_abnormal_social/conspecific_i | 0.71708163 |
| 168 | MP0003806_abnormal_nucleotide_metabolis | 0.70648136 |
| 169 | MP0005535_abnormal_body_temperature | 0.70425486 |
| 170 | MP0002229_neurodegeneration | 0.70418403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Epiphyseal dysplasia (HP:0002656) | 6.32340714 |
| 2 | Petechiae (HP:0000967) | 6.22633615 |
| 3 | Irregular epiphyses (HP:0010582) | 5.77200613 |
| 4 | Cupped ribs (HP:0000887) | 5.22607621 |
| 5 | Abnormal tarsal ossification (HP:0008369) | 4.82985513 |
| 6 | Flat acetabular roof (HP:0003180) | 4.79636246 |
| 7 | Abnormal platelet volume (HP:0011876) | 4.29477158 |
| 8 | Increased mean platelet volume (HP:0011877) | 4.25752185 |
| 9 | Decreased circulating renin level (HP:0003351) | 4.16222362 |
| 10 | Abnormal platelet function (HP:0011869) | 3.96428223 |
| 11 | Impaired platelet aggregation (HP:0003540) | 3.96428223 |
| 12 | Vitreoretinal degeneration (HP:0000655) | 3.85351980 |
| 13 | Flat capital femoral epiphysis (HP:0003370) | 3.78139062 |
| 14 | Pancreatic cysts (HP:0001737) | 3.73504225 |
| 15 | Abnormal foot bone ossification (HP:0010675) | 3.72775065 |
| 16 | Prolonged bleeding time (HP:0003010) | 3.71720965 |
| 17 | Genu varum (HP:0002970) | 3.71587268 |
| 18 | Abnormality of vitamin B metabolism (HP:0004340) | 3.65757228 |
| 19 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.61721279 |
| 20 | Purpura (HP:0000979) | 3.55033408 |
| 21 | Small epiphyses (HP:0010585) | 3.50268735 |
| 22 | Abnormality of renin-angiotensin system (HP:0000847) | 3.48342543 |
| 23 | Delayed epiphyseal ossification (HP:0002663) | 3.47816554 |
| 24 | Menorrhagia (HP:0000132) | 3.39642148 |
| 25 | Pancreatic fibrosis (HP:0100732) | 3.27972067 |
| 26 | Congenital stationary night blindness (HP:0007642) | 3.24612364 |
| 27 | Abnormality of carpal bone ossification (HP:0006257) | 3.20369368 |
| 28 | Gingival bleeding (HP:0000225) | 3.19484473 |
| 29 | True hermaphroditism (HP:0010459) | 3.10307539 |
| 30 | Right ventricular cardiomyopathy (HP:0011663) | 3.05758866 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 3.05425732 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 3.05425732 |
| 33 | Hypoplastic ischia (HP:0003175) | 3.03163469 |
| 34 | Metaphyseal irregularity (HP:0003025) | 3.01505719 |
| 35 | White forelock (HP:0002211) | 3.00230421 |
| 36 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.97512800 |
| 37 | Abnormality of femoral epiphyses (HP:0006499) | 2.97512800 |
| 38 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.96002994 |
| 39 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.95262648 |
| 40 | Absent/shortened dynein arms (HP:0200106) | 2.95262648 |
| 41 | Confusion (HP:0001289) | 2.92665221 |
| 42 | Metabolic alkalosis (HP:0200114) | 2.91113493 |
| 43 | Abnormality of the renal cortex (HP:0011035) | 2.89677957 |
| 44 | Alkalosis (HP:0001948) | 2.89463973 |
| 45 | Abnormal drinking behavior (HP:0030082) | 2.89180595 |
| 46 | Polydipsia (HP:0001959) | 2.89180595 |
| 47 | Abolished electroretinogram (ERG) (HP:0000550) | 2.82314115 |
| 48 | Short femoral neck (HP:0100864) | 2.82097690 |
| 49 | Metaphyseal dysplasia (HP:0100255) | 2.81282837 |
| 50 | Flattened epiphyses (HP:0003071) | 2.80185146 |
| 51 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.79523008 |
| 52 | Chronic diarrhea (HP:0002028) | 2.77647013 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 2.76935555 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.76935555 |
| 55 | Nephronophthisis (HP:0000090) | 2.76567396 |
| 56 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.75781123 |
| 57 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.75781123 |
| 58 | Patchy hypopigmentation of hair (HP:0011365) | 2.75548226 |
| 59 | Neonatal short-limb short stature (HP:0008921) | 2.72962379 |
| 60 | Hyperglycinuria (HP:0003108) | 2.72411409 |
| 61 | Abnormality of urine glucose concentration (HP:0011016) | 2.71465981 |
| 62 | Glycosuria (HP:0003076) | 2.71465981 |
| 63 | Abnormality of the vertebral endplates (HP:0005106) | 2.69852616 |
| 64 | Abnormality of vitamin metabolism (HP:0100508) | 2.68399816 |
| 65 | Methylmalonic aciduria (HP:0012120) | 2.68171516 |
| 66 | Abnormal vertebral ossification (HP:0100569) | 2.67825469 |
| 67 | Abnormal ciliary motility (HP:0012262) | 2.67457431 |
| 68 | Abnormality of the femoral head (HP:0003368) | 2.65231346 |
| 69 | Cervical subluxation (HP:0003308) | 2.59588009 |
| 70 | Increased IgE level (HP:0003212) | 2.58989216 |
| 71 | Abnormality of the ischium (HP:0003174) | 2.57993375 |
| 72 | Hyperactive renin-angiotensin system (HP:0000841) | 2.57628100 |
| 73 | Abnormality of the renal medulla (HP:0100957) | 2.54643404 |
| 74 | Pigmentary retinal degeneration (HP:0001146) | 2.53221099 |
| 75 | Abnormality of glycine metabolism (HP:0010895) | 2.52749175 |
| 76 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.52749175 |
| 77 | Tubular atrophy (HP:0000092) | 2.51488870 |
| 78 | Hyperventilation (HP:0002883) | 2.50544710 |
| 79 | Abnormal hand bone ossification (HP:0010660) | 2.48379123 |
| 80 | Enlarged epiphyses (HP:0010580) | 2.48251558 |
| 81 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.46464218 |
| 82 | Abnormality of magnesium homeostasis (HP:0004921) | 2.46286706 |
| 83 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.43731448 |
| 84 | Abnormal urine output (HP:0012590) | 2.43080344 |
| 85 | Cystic liver disease (HP:0006706) | 2.42981665 |
| 86 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.40807442 |
| 87 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.40604904 |
| 88 | Polyuria (HP:0000103) | 2.39283048 |
| 89 | Abnormality of renal excretion (HP:0011036) | 2.39127711 |
| 90 | Hypomagnesemia (HP:0002917) | 2.38877586 |
| 91 | Recurrent fungal infections (HP:0002841) | 2.36631147 |
| 92 | Disproportionate short-trunk short stature (HP:0003521) | 2.35486877 |
| 93 | Abnormality of incisor morphology (HP:0011063) | 2.34108220 |
| 94 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.32241239 |
| 95 | Chorioretinal atrophy (HP:0000533) | 2.31691379 |
| 96 | Malnutrition (HP:0004395) | 2.30686628 |
| 97 | Abnormal ossification of hand bones (HP:0005921) | 2.30099113 |
| 98 | Abnormality of chloride homeostasis (HP:0011422) | 2.29449850 |
| 99 | Stillbirth (HP:0003826) | 2.25870586 |
| 100 | Metaphyseal cupping (HP:0003021) | 2.25632257 |
| 101 | Ovoid vertebral bodies (HP:0003300) | 2.24967044 |
| 102 | Ketoacidosis (HP:0001993) | 2.24614246 |
| 103 | Proximal tubulopathy (HP:0000114) | 2.24074816 |
| 104 | Attenuation of retinal blood vessels (HP:0007843) | 2.22654816 |
| 105 | Potter facies (HP:0002009) | 2.21831677 |
| 106 | Facial shape deformation (HP:0011334) | 2.21831677 |
| 107 | Autoimmune hemolytic anemia (HP:0001890) | 2.21657673 |
| 108 | Ketosis (HP:0001946) | 2.20451875 |
| 109 | Hypokalemia (HP:0002900) | 2.20214987 |
| 110 | Methylmalonic acidemia (HP:0002912) | 2.19857457 |
| 111 | Thoracolumbar scoliosis (HP:0002944) | 2.19775257 |
| 112 | Spinal cord compression (HP:0002176) | 2.19720165 |
| 113 | Renal cortical cysts (HP:0000803) | 2.18660264 |
| 114 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.18431269 |
| 115 | Absent epiphyses (HP:0010577) | 2.18431269 |
| 116 | Increased circulating renin level (HP:0000848) | 2.17048325 |
| 117 | Hypothermia (HP:0002045) | 2.15714955 |
| 118 | Furrowed tongue (HP:0000221) | 2.14657817 |
| 119 | Rhinitis (HP:0012384) | 2.14227734 |
| 120 | Pendular nystagmus (HP:0012043) | 2.12789443 |
| 121 | Gaze-evoked nystagmus (HP:0000640) | 2.12679743 |
| 122 | Chronic hepatic failure (HP:0100626) | 2.09351278 |
| 123 | Barrel-shaped chest (HP:0001552) | 2.09004936 |
| 124 | Prostate neoplasm (HP:0100787) | 2.08888923 |
| 125 | Abdominal distention (HP:0003270) | 2.08295173 |
| 126 | Hyperaldosteronism (HP:0000859) | 2.06305627 |
| 127 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.06139068 |
| 128 | Irregular vertebral endplates (HP:0003301) | 2.05777550 |
| 129 | Autoimmune thrombocytopenia (HP:0001973) | 2.05361759 |
| 130 | Clumsiness (HP:0002312) | 2.05204197 |
| 131 | Recurrent viral infections (HP:0004429) | 2.04918369 |
| 132 | Retrobulbar optic neuritis (HP:0100654) | 2.04746688 |
| 133 | Optic neuritis (HP:0100653) | 2.04746688 |
| 134 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.03635785 |
| 135 | Abnormal albumin level (HP:0012116) | 2.02053650 |
| 136 | Hypoalbuminemia (HP:0003073) | 2.02053650 |
| 137 | Congenital, generalized hypertrichosis (HP:0004540) | 2.01281221 |
| 138 | Beaking of vertebral bodies (HP:0004568) | 2.00520936 |
| 139 | Abnormality of the lumbar spine (HP:0100712) | 2.00071606 |
| 140 | Coxa vara (HP:0002812) | 1.99702246 |
| 141 | Protuberant abdomen (HP:0001538) | 1.98633953 |
| 142 | Decreased central vision (HP:0007663) | 1.98148490 |
| 143 | Genetic anticipation (HP:0003743) | 1.97641536 |
| 144 | Medial flaring of the eyebrow (HP:0010747) | 1.96572489 |
| 145 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.95057467 |
| 146 | Tetany (HP:0001281) | 1.93639687 |
| 147 | Stomach cancer (HP:0012126) | 1.91284327 |
| 148 | Plantar hyperkeratosis (HP:0007556) | 1.90059997 |
| 149 | Congenital sensorineural hearing impairment (HP:0008527) | 1.89794322 |
| 150 | Platyspondyly (HP:0000926) | 1.89681937 |
| 151 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.89134454 |
| 152 | Recurrent abscess formation (HP:0002722) | 1.88092283 |
| 153 | Congenital hepatic fibrosis (HP:0002612) | 1.87620532 |
| 154 | Onycholysis (HP:0001806) | 1.86703366 |
| 155 | Hypoplasia of the odontoid process (HP:0003311) | 1.86511087 |
| 156 | Metabolic acidosis (HP:0001942) | 1.86504946 |
| 157 | Osteoarthritis (HP:0002758) | 1.86457803 |
| 158 | Recurrent bacterial skin infections (HP:0005406) | 1.86015577 |
| 159 | Waddling gait (HP:0002515) | 1.85093932 |
| 160 | Abnormality of potassium homeostasis (HP:0011042) | 1.84897642 |
| 161 | Hypokalemic alkalosis (HP:0001949) | 1.84682478 |
| 162 | Hypoplastic ilia (HP:0000946) | 1.84615368 |
| 163 | Epistaxis (HP:0000421) | 1.83943694 |
| 164 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.83555226 |
| 165 | Orchitis (HP:0100796) | 1.83411918 |
| 166 | Progressive cerebellar ataxia (HP:0002073) | 1.82908510 |
| 167 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.82868766 |
| 168 | Type II lissencephaly (HP:0007260) | 1.81793012 |
| 169 | Myositis (HP:0100614) | 1.81402347 |
| 170 | Increased corneal curvature (HP:0100692) | 1.81307808 |
| 171 | Keratoconus (HP:0000563) | 1.81307808 |
| 172 | Limited elbow extension (HP:0001377) | 1.79928507 |
| 173 | Vertebral hypoplasia (HP:0008417) | 1.79809526 |
| 174 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.79809526 |
| 175 | Widely patent fontanelles and sutures (HP:0004492) | 1.78946378 |
| 176 | IgM deficiency (HP:0002850) | 1.78541039 |
| 177 | Abnormality of eosinophils (HP:0001879) | 1.78476587 |
| 178 | Lethargy (HP:0001254) | 1.77541565 |
| 179 | Large for gestational age (HP:0001520) | 1.77394476 |
| 180 | Dicarboxylic aciduria (HP:0003215) | 1.77153326 |
| 181 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.77153326 |
| 182 | Male pseudohermaphroditism (HP:0000037) | 1.77120801 |
| 183 | Hypobetalipoproteinemia (HP:0003563) | 1.76741999 |
| 184 | Milia (HP:0001056) | 1.76248532 |
| 185 | Heterochromia iridis (HP:0001100) | 1.75802792 |
| 186 | Bronchiectasis (HP:0002110) | 1.75268379 |
| 187 | Ileus (HP:0002595) | 1.74625277 |
| 188 | Hyperalaninemia (HP:0003348) | 1.74612487 |
| 189 | Abnormality of the 2nd finger (HP:0004100) | 1.72012706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 5.07194977 |
| 2 | MST4 | 4.48033161 |
| 3 | FRK | 3.75663208 |
| 4 | NME1 | 3.66215038 |
| 5 | KIT | 3.33913311 |
| 6 | EEF2K | 3.29284116 |
| 7 | ADRBK2 | 3.09469300 |
| 8 | TXK | 2.92922746 |
| 9 | MATK | 2.81189190 |
| 10 | MAP3K14 | 2.61494164 |
| 11 | PIM2 | 2.51542548 |
| 12 | TLK1 | 2.47598424 |
| 13 | STK39 | 2.46037719 |
| 14 | MAPKAPK3 | 2.38817647 |
| 15 | TRPM7 | 2.29104436 |
| 16 | WNK4 | 2.23990675 |
| 17 | MAP3K3 | 2.22944293 |
| 18 | STK24 | 2.19908929 |
| 19 | MST1R | 2.15209501 |
| 20 | IRAK3 | 2.14550553 |
| 21 | MAP4K2 | 2.12454332 |
| 22 | PRKG2 | 2.06673351 |
| 23 | INSRR | 1.92322949 |
| 24 | PINK1 | 1.86512558 |
| 25 | RIPK4 | 1.75526242 |
| 26 | MAP4K1 | 1.64254570 |
| 27 | DAPK2 | 1.47557009 |
| 28 | IRAK4 | 1.44736747 |
| 29 | NUAK1 | 1.43427777 |
| 30 | MAP3K12 | 1.40461646 |
| 31 | TAOK3 | 1.39635009 |
| 32 | SIK3 | 1.39433125 |
| 33 | STK10 | 1.38625672 |
| 34 | FGFR3 | 1.32624660 |
| 35 | RPS6KB2 | 1.28275239 |
| 36 | MAPK13 | 1.27142193 |
| 37 | TNIK | 1.26731797 |
| 38 | MAPKAPK5 | 1.24072309 |
| 39 | TEC | 1.22832181 |
| 40 | TYK2 | 1.19573463 |
| 41 | PTK6 | 1.17337064 |
| 42 | JAK3 | 1.17043709 |
| 43 | MUSK | 1.09750864 |
| 44 | PIM1 | 1.09558910 |
| 45 | ADRBK1 | 1.08775099 |
| 46 | BMPR2 | 1.07973543 |
| 47 | BMPR1B | 1.07457277 |
| 48 | SYK | 1.07019707 |
| 49 | PDK2 | 1.03365038 |
| 50 | ERBB3 | 1.03283556 |
| 51 | TBK1 | 1.02966535 |
| 52 | BTK | 1.02335862 |
| 53 | MAPK15 | 1.02095856 |
| 54 | STK3 | 0.96520154 |
| 55 | EPHA3 | 0.96271438 |
| 56 | PRKCE | 0.95188242 |
| 57 | NEK9 | 0.94847955 |
| 58 | CASK | 0.92146511 |
| 59 | IKBKB | 0.90734088 |
| 60 | GRK6 | 0.90560945 |
| 61 | MAPKAPK2 | 0.90387447 |
| 62 | ITK | 0.89626971 |
| 63 | WNK3 | 0.86223337 |
| 64 | MAP2K6 | 0.85752290 |
| 65 | CDK6 | 0.85250504 |
| 66 | GRK7 | 0.81287709 |
| 67 | MAP3K4 | 0.77770724 |
| 68 | LYN | 0.77382423 |
| 69 | YES1 | 0.74839645 |
| 70 | LMTK2 | 0.74561994 |
| 71 | CAMKK2 | 0.73042151 |
| 72 | ERBB2 | 0.72668403 |
| 73 | BCKDK | 0.72488147 |
| 74 | STK38L | 0.71878548 |
| 75 | PAK3 | 0.71836173 |
| 76 | OXSR1 | 0.71467295 |
| 77 | MAP3K7 | 0.69751650 |
| 78 | TIE1 | 0.68940624 |
| 79 | TRIM28 | 0.68645873 |
| 80 | CSF1R | 0.68060297 |
| 81 | PRKCQ | 0.68018286 |
| 82 | AKT3 | 0.66391318 |
| 83 | EPHB2 | 0.66368122 |
| 84 | EPHB1 | 0.66141653 |
| 85 | IKBKE | 0.65641934 |
| 86 | PRKAA2 | 0.65538820 |
| 87 | JAK2 | 0.65235955 |
| 88 | NLK | 0.65179877 |
| 89 | PLK2 | 0.64181059 |
| 90 | PIK3CG | 0.63326114 |
| 91 | CHUK | 0.63000913 |
| 92 | PRKCA | 0.62019511 |
| 93 | GRK1 | 0.61901389 |
| 94 | PTK2B | 0.60896623 |
| 95 | CDK3 | 0.60547393 |
| 96 | SGK3 | 0.59707662 |
| 97 | PHKG2 | 0.59524633 |
| 98 | PHKG1 | 0.59524633 |
| 99 | CSNK1A1 | 0.59066554 |
| 100 | ZAK | 0.56964209 |
| 101 | PIK3CA | 0.56714797 |
| 102 | NTRK3 | 0.56543366 |
| 103 | MAP3K11 | 0.55632087 |
| 104 | LCK | 0.55082548 |
| 105 | PRKACA | 0.55002908 |
| 106 | MAP2K2 | 0.54962424 |
| 107 | LRRK2 | 0.54299141 |
| 108 | FES | 0.53124375 |
| 109 | DDR2 | 0.52482030 |
| 110 | CAMK2A | 0.52258392 |
| 111 | MAP3K6 | 0.50383002 |
| 112 | SGK2 | 0.49366486 |
| 113 | MAP2K1 | 0.48503114 |
| 114 | IGF1R | 0.48243505 |
| 115 | PRKCI | 0.48139758 |
| 116 | FGFR2 | 0.47612867 |
| 117 | PRKCZ | 0.47555984 |
| 118 | PRKCG | 0.47451440 |
| 119 | MAPK11 | 0.47394433 |
| 120 | BRSK2 | 0.44565612 |
| 121 | MKNK2 | 0.43245859 |
| 122 | MAP3K5 | 0.42972340 |
| 123 | IRAK1 | 0.42754971 |
| 124 | EPHA4 | 0.42485947 |
| 125 | RPS6KA2 | 0.41236312 |
| 126 | EIF2AK3 | 0.41216389 |
| 127 | TAOK1 | 0.40991602 |
| 128 | PRKACG | 0.40458456 |
| 129 | DYRK1B | 0.39696036 |
| 130 | HCK | 0.39359162 |
| 131 | CSNK1G1 | 0.39123959 |
| 132 | CSNK1G2 | 0.38799470 |
| 133 | TGFBR1 | 0.36598626 |
| 134 | MYLK | 0.36494584 |
| 135 | CSK | 0.36270545 |
| 136 | TNK2 | 0.35581179 |
| 137 | TAOK2 | 0.35035336 |
| 138 | FER | 0.34839658 |
| 139 | GRK5 | 0.34659163 |
| 140 | PRKCD | 0.34228446 |
| 141 | CDK9 | 0.33603448 |
| 142 | JAK1 | 0.32226358 |
| 143 | CSNK1G3 | 0.32123747 |
| 144 | EIF2AK2 | 0.32071230 |
| 145 | PRKAA1 | 0.31913486 |
| 146 | PRKG1 | 0.31702431 |
| 147 | CAMK2D | 0.31491029 |
| 148 | PRKD2 | 0.31309529 |
| 149 | NME2 | 0.29778178 |
| 150 | ABL1 | 0.29726582 |
| 151 | MAP3K2 | 0.29433868 |
| 152 | NTRK2 | 0.28709937 |
| 153 | TGFBR2 | 0.28516225 |
| 154 | ZAP70 | 0.28310377 |
| 155 | MAPK4 | 0.28220231 |
| 156 | EPHA2 | 0.27789610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Renin-angiotensin system_Homo sapiens_hsa04614 | 6.98217581 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.59551533 |
| 3 | Protein digestion and absorption_Homo sapiens_hsa04974 | 3.17300532 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.59397285 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 2.52507228 |
| 6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.42134421 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.37968662 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.25421048 |
| 9 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.21424916 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.21305293 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.20947051 |
| 12 | Retinol metabolism_Homo sapiens_hsa00830 | 2.01896964 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.98216007 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95616654 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.92820734 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88559105 |
| 17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.85300096 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80949198 |
| 19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.80871927 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.76013791 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.72162961 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.60006858 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.59758415 |
| 24 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.56343351 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55699101 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.51068104 |
| 27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.44877442 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44850626 |
| 29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.43335609 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.41466196 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38939507 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.37484496 |
| 33 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.37322861 |
| 34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.36260731 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 1.34904745 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31021261 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29365881 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27311688 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.23646296 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22664225 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.21625770 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.20969594 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.20128037 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17953417 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17149767 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15508065 |
| 47 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.14181151 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.14127744 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.12445905 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.10477339 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.09514418 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.09250034 |
| 53 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.06036911 |
| 54 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05499602 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 1.04367105 |
| 56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03854554 |
| 57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.03850542 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02274079 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02001483 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.97002558 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.96716188 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95639535 |
| 63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95441785 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 0.95093322 |
| 65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94541248 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92314991 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.92137754 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90701716 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89507672 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85785208 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85140344 |
| 72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.84221929 |
| 73 | Measles_Homo sapiens_hsa05162 | 0.84058941 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83573866 |
| 75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81297964 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.80101482 |
| 77 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79508563 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79202418 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78493340 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75707223 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.75275813 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74867853 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74447328 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.74139808 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73761601 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73399816 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.73188215 |
| 88 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71139224 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69654169 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69575143 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.69365373 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66747312 |
| 93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66392565 |
| 94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66066833 |
| 95 | Taste transduction_Homo sapiens_hsa04742 | 0.65789303 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63901490 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.62806927 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61194912 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.61177967 |
| 100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59937023 |
| 101 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59046490 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.58247312 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58246198 |
| 104 | Salmonella infection_Homo sapiens_hsa05132 | 0.58104679 |
| 105 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57749603 |
| 106 | Salivary secretion_Homo sapiens_hsa04970 | 0.57671462 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57198890 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56440251 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55844787 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55467890 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55354089 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54840363 |
| 113 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54568859 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53762319 |
| 115 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53650546 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52996706 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52851560 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52539613 |
| 119 | Bile secretion_Homo sapiens_hsa04976 | 0.51043006 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49766229 |
| 121 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49395321 |
| 122 | Shigellosis_Homo sapiens_hsa05131 | 0.47681596 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46626769 |
| 124 | Olfactory transduction_Homo sapiens_hsa04740 | 0.44277008 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43964491 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.43843799 |
| 127 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42840284 |
| 128 | Homologous recombination_Homo sapiens_hsa03440 | 0.42808518 |
| 129 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42709419 |
| 130 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.42631949 |
| 131 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41850824 |
| 132 | Parkinsons disease_Homo sapiens_hsa05012 | 0.41685649 |
| 133 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.41544377 |
| 134 | Focal adhesion_Homo sapiens_hsa04510 | 0.41355293 |
| 135 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.40945163 |
| 136 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40699182 |
| 137 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40465157 |
| 138 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40356525 |
| 139 | Morphine addiction_Homo sapiens_hsa05032 | 0.39565729 |
| 140 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37519726 |
| 141 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.37449644 |
| 142 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36821057 |
| 143 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.36766487 |
| 144 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36299630 |
| 145 | Circadian entrainment_Homo sapiens_hsa04713 | 0.35896710 |
| 146 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35728357 |
| 147 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35104732 |
| 148 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35028013 |
| 149 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34833751 |
| 150 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34796381 |
| 151 | Protein export_Homo sapiens_hsa03060 | 0.33212927 |
| 152 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32299205 |
| 153 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.32088545 |
| 154 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.31524236 |
| 155 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31490632 |
| 156 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31064125 |
| 157 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30925039 |
| 158 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30156216 |
| 159 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29917339 |
| 160 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.28466868 |

